The global mortality data for musculoskeletal system and connective tissue diseases reveals considerable variation across countries. In 2024, Spain leads with the highest mortality rate, while Romania has the lowest. Over the past year, variations show notable declines in mortality rates in Luxembourg, Colombia, and Slovakia. In contrast, Costa Rica and Greece experienced significant increases. The 5-year CAGR highlights a general trend of moderate increases and decreases, reflecting regional differences in healthcare advancements and population demographics.
Future trends to watch include advancements in healthcare technologies, aging populations, and lifestyle changes, which can affect mortality rates due to musculoskeletal and connective tissue diseases. Monitoring these trends will be crucial for forecasting future healthcare needs and policy-making decisions worldwide.
Top countries in Musculoskeletal System and Connective Tissue Diseases Mortality by Country
| # | 10 Countries | Units (Female Deaths) Per Hundred Thousand Women | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Spain | 14 | 2023 | -0.71% | -0.84% | View data |
| 2 | 2 Switzerland | 10.2 | 2023 | 0% | -1.68% | View data |
| 3 | 3 Japan | 8.8 | 2023 | +1.15% | +1.18% | View data |
| 4 | 4 Germany | 8.8 | 2023 | +1.15% | +2.18% | View data |
| 5 | 5 Netherlands | 8.2 | 2023 | +1.23% | -0.95% | View data |
| 6 | 6 United Kingdom | 7.8 | 2023 | 0% | -1.23% | View data |
| 7 | 7 Denmark | 7.6 | 2023 | +1.33% | +0.81% | View data |
| 8 | 8 Belgium | 7.4 | 2023 | +1.37% | +1.41% | View data |
| 9 | 9 Australia | 7.1 | 2023 | +2.9% | +1.47% | View data |
| 10 | 10 Canada | 7 | 2023 | +1.45% | +1.18% | View data |
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...
